Dr. Gabriel Sosne To Present New T?4 Anti-Inflammation Data At ARVO

Regenerx Biopharmaceuticals, Inc. (Amex:Rgn) announced that Dr. Gabriel Sosne, Assistant Professor of Ophthalmology at Wayne State University School of Medicine and the Kresge Eye Institute in Detroit, MI, will be presenting data from a new study entitled, “Lipid Rafts and Actin Are Important for Thymosin Beta 4-Mediated Anti-Inflammatory Effects in the Cornea,” on Tuesday, April […]

Popularity: 10% [?]

Tags: , , , , ,

Metabasis Completes Enrollment Of Its Proof-of-Concept Clinical Trial For MB07803, Its Product Candidate For The Treatment Of Type 2 Diabetes

Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced the completion of patient enrollment in its Phase 2a clinical trial for MB07803, a product candidate being studied as a treatment for patients with type 2 diabetes. With this trial fully enrolled and the final patients undergoing dosing, the Company expects to be able to announce top line results in […]

Popularity: 6% [?]

Tags: , , , , , ,

Teva Announces Approval Of Generic Camptosar(R)

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer’s chemotherapy agent, Camptosar(R) (Irinotecan Hydrochloride) Injection, 20 mg/mL. Shipment of this product, available in 40 mg/2 mL and 100 mg/5 mL single […]

Popularity: 6% [?]

Tags: , , , , , , , ,

International Stem Cell Corporation’s Human Parthenogenetic Stem Cells To Be Used In Germany In The Development Of Treatments For Neural Disease

International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson’s disease.
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany under a Material Transfer Agreement […]

Popularity: 4% [?]

Tags: , , , , , , , , , , , ,

Three State Boards Of Education Awarded HIV Prevention Grants By National Association Of State Boards Of Education

The National Association of State Boards of Education (NASBE) has made grants to three state boards of education to promote more effective instruction to K-12 students about HIV prevention. The $13,000 grants are being made to the North Carolina, Oregon, and Tennessee State Boards of Education.
“HIV remains a dire threat to public health. And as […]

Popularity: 1% [?]

Tags: , , , , , , , ,

Hatch Medical To Broker Chronic Total Occlusion Device

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced that it has recently entered into an agreement with Medical Miracles (Leeds, UK) to broker its patented and CE Marked chronic total occlusion (CTO) device, POLAR™.
POLAR™ (Path Of Least Arterial Resistance) is a mechanical device that generates reciprocal and lateral movements at the […]

Popularity: 1% [?]

Tags: , , , , , ,

CONMED Corporation To Present At The Canaccord Adams Small Cap Orthopedics Conference On Tuesday, March 4, 2008

CONMED Corporation (Nasdaq: CNMD), a medical technology company specializing in medical devices for surgical and patient monitoring markets, announced today that the Company will participate in The Canaccord Adams Small Cap Orthopedics Conference on Tuesday, March 4, 2008 at 1:30 PM Pacific time. The event will be held in San Francisco at the Mission Bay […]

Popularity: 1% [?]

Tags: , , , , , , , , , ,

How The Brain Learns, And The Role Of Time And Timing In Education, To Be Discussed At ”Science Of Learning” Forum, USA

Can a better understanding of the science of learning help us educate our students? Researchers at the Temporal Dynamics of Learning Center (TDLC), a National Science Foundation Science of Learning Center, think so. To address the issue the TDLC is hosting a forum titled, “Brains R Us: The Science of Educating,” a free, open to […]

Popularity: 1% [?]

Tags: , , , , , , , , ,

Biothera Drug Synergistic With Avastin(R) Against Cancer, Study Finds

Biothera’s Imprime PGG™ increased the effectiveness of Avastin(R) (bevacizumab), a monoclonal antibody approved for the treatment of metastatic colorectal, breast and non-small cell lung cancer, according to a new preclinical study published in the current issue of Clinical Cancer Research.
Researchers in the Tumor Immunobiology Program of the James Graham Brown Cancer Center, University of Louisville, […]

Popularity: 1% [?]

Tags: , , , , , , , , ,